2 news items
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
MBRX
13 May 24
or Death
Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data
MBRX
7 May 24
) is 4.9 months and climbing. DoR is defined as the time from initiation of treatment to the point of disease relapse or death. At the end
- Prev
- 1
- Next